These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6026527)

  • 1. Stability of earliest memories under LSD-25 and placebo.
    Langs RJ
    J Nerv Ment Dis; 1967 Mar; 144(3):171-84. PubMed ID: 6026527
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysergic acid diethylamide (LSD-25) and schizophrenic reactions. A comparative study.
    Langs RJ; Barr HL
    J Nerv Ment Dis; 1968 Aug; 147(2):163-72. PubMed ID: 5677324
    [No Abstract]   [Full Text] [Related]  

  • 3. Placebo reactions in a study of lysergic acid diethylamide (LSD-25).
    LINTON HB; LANGS RJ
    Arch Gen Psychiatry; 1962 May; 6():369-83. PubMed ID: 14465662
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of LSD-25 on creativity and tolerance to regression.
    Zegans LS; Pollard JC; Brown D
    Arch Gen Psychiatry; 1967 Jun; 16(6):740-9. PubMed ID: 5338679
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of lysergic acid diethylamide on memory in mice].
    Chaplygina SR
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1975; 25(1):66-9. PubMed ID: 1210683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Personality traits and course of LSD intoxication].
    Karsevová D; Kratochvíl S; Müllerová J
    Cesk Psychiatr; 1969 Jun; 65(3):159-63. PubMed ID: 5790307
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterizing the psychological state produced by LSD.
    Katz MM; Waskow IE; Olsson J
    J Abnorm Psychol; 1968 Feb; 73(1):1-14. PubMed ID: 5639999
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive test performance under LSD-25, placebo and isolation.
    Goldberger L
    J Nerv Ment Dis; 1966 Jan; 142(1):4-9. PubMed ID: 5326508
    [No Abstract]   [Full Text] [Related]  

  • 9. Long lasting effects of LSD on normals.
    McGlothlin W; Cohen S; McGlothlin MS
    Arch Gen Psychiatry; 1967 Nov; 17(5):521-32. PubMed ID: 6054248
    [No Abstract]   [Full Text] [Related]  

  • 10. [Authenticity and sole of regressive experiences during analytical LSD psychotherapy].
    Havlícek Z
    Cesk Psychiatr; 1968 Aug; 64(4):236-40. PubMed ID: 5680671
    [No Abstract]   [Full Text] [Related]  

  • 11. Motivation for self-administration of LSD.
    Frosch WA; Robbins E; Robbins L; Stern M
    Psychiatr Q; 1967 Jan; 41(1):56-61. PubMed ID: 6036622
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of D-lysergic acid diethylamide (LSD-25) on learning and retention.
    ARONSON H; WATERMANN CE; KLEE GD
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1962; 23():17-23. PubMed ID: 13862516
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effects of steroids on LSD-25 action in man.
    Krus DM; Bergen JR; Resnick O
    Life Sci; 1967 Apr; 6(7):691-701. PubMed ID: 6031252
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavior of the salamander under the influence of LSD-25 and Frenquel, and accompanying electrical activity of brain and spinal cord.
    PETERS JJ; VONDERAHE AR
    J Nerv Ment Dis; 1956 Jul; 124(1):69-73. PubMed ID: 13416922
    [No Abstract]   [Full Text] [Related]  

  • 15. Mental age regression induced by lysergic acid diethylamide.
    Lienert G
    J Psychol; 1966 May; 63(1):3-11. PubMed ID: 5944667
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysergic acid diethylamide tartrate (LSD-25) dosage levels, group differences and social interaction.
    Cheek FE; Holstein CM
    J Nerv Ment Dis; 1971 Aug; 153(2):133-47. PubMed ID: 5572106
    [No Abstract]   [Full Text] [Related]  

  • 17. Speech rhythms in patient monologues: the influence of LSD-25 and dextroamphetamine.
    Jaffe J; Dahlberg CC; Luria J; Breskin S; Chorosh J; Lorick E
    Biol Psychiatry; 1972 Jun; 4(3):243-6. PubMed ID: 5041919
    [No Abstract]   [Full Text] [Related]  

  • 18. Reaction time ("mental set") in control and chronic schizophrenic subjects and in postaddicts under placebo, LSD-25, morphine, pentobarbital and amphetamine.
    Wikler A; Haertzen CA; Chessick RD; Hill HE; Pescor FT
    Psychopharmacologia; 1965 May; 7(6):423-43. PubMed ID: 5319301
    [No Abstract]   [Full Text] [Related]  

  • 19. The schizophrenias as nervous types.
    Claridge G
    Br J Psychiatry; 1972 Jul; 121(560):1-17. PubMed ID: 5047166
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of lysergic acid and sodium amytal on immediate memory and expressive movement.
    BRENGELMANN JC; LAVERTY SG; LEWIS DJ
    J Ment Sci; 1958 Jan; 104(434):144-52. PubMed ID: 13514453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.